PHOENIX, AZ - February 02, 2026 - PRESSADVANTAGE - Phoenix NP, a women-focused telehealth medical practice based in ...
PHILADELPHIA -- At Roxborough Memorial Hospital in Philadelphia, surgeon Piotr Krecioch has his hands full launching a ...
An anti-doping group is keeping a close eye on the use of these obesity and diabetes drugs in elite athletes. Here’s why.
New approaches to obesity treatment are emerging as scientists target underexplored metabolic pathways with the help of artificial intelligence. Demand for better obesity medicines is rising quickly, ...
1-2 pounds in a week is a safe amount to lose, per the CDC. Foodtrainers offers a one-week program for clients with an ...
Creatine is a popular workout supplement, and some people use it to support weight loss. Learn how this supplement ...
ClearBridge explores the 2025 market dominated by mega-cap tech and growing speculative AI risks. Read their latest strategy update and market outlook now.
President and Chief Executive Officer — Shawn K. Singh Chief Operating Officer — Joshua S. Prince Vice President, Corporate Development & Investor Relations — Mark McPartland Need a quote from a ...
A small decision with big consequences.
Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.
Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results